Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Sun Pharmaceutical Industries LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524715NSE Symbol: SUNPHARMAP/E(TTM):127.06
ISIN Demat:INE044A01036Div & Yield %:0.81EPS(TTM):13.13
Book Value(Rs):98.3315118Market Cap ( Cr.):400293.05Face Value(Rs):1
    Change Company 
Date Headline
07-Apr-25 Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India
07-Apr-25 Sun Pharma launches Fexuprazan tablets 40 mg in India
27-Mar-25 Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Updates
26-Mar-25 Sun Pharmaceutical Industries Ltd - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requireme..
18-Mar-25 Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada
18-Mar-25 Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million
18-Mar-25 Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Updates on Acquisition
17-Mar-25 Sun Pharmaceuticals Industries Ltd soars 0.96%, gains for fifth straight session
12-Mar-25 Sun Pharmaceuticals Industries Ltd rises for third straight session
10-Mar-25 Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics
<< < 1 2 3 4   > >>